Marvel Biosciences Announces Positive Interim Results for Autism Treatment with MB204
substantial potential of MB204 to address the core symptoms of autism.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 CAD | 0.00% | +4.55% | +43.75% |
1st Jan change | Capi. | |
---|---|---|
+43.75% | 3.34M | |
+21.22% | 46.93B | |
+37.63% | 39.08B | |
-8.38% | 38.48B | |
+28.65% | 31.01B | |
-13.75% | 26.14B | |
+11.31% | 25.88B | |
+35.89% | 12.53B | |
-6.49% | 11.36B | |
-12.36% | 10.65B |